256 related articles for article (PubMed ID: 22541166)
1. Dysfunctional hippocampal activity affects emotion and cognition in mood disorders.
Femenía T; Gómez-Galán M; Lindskog M; Magara S
Brain Res; 2012 Oct; 1476():58-70. PubMed ID: 22541166
[TBL] [Abstract][Full Text] [Related]
2. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.
Sanacora G; Treccani G; Popoli M
Neuropharmacology; 2012 Jan; 62(1):63-77. PubMed ID: 21827775
[TBL] [Abstract][Full Text] [Related]
3. Critical role of brain-derived neurotrophic factor in mood disorders.
Hashimoto K; Shimizu E; Iyo M
Brain Res Brain Res Rev; 2004 May; 45(2):104-14. PubMed ID: 15145621
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of GABAergic neurotransmission in mood disorders: a postmortem study.
Bielau H; Steiner J; Mawrin C; Trübner K; Brisch R; Meyer-Lotz G; Brodhun M; Dobrowolny H; Baumann B; Gos T; Bernstein HG; Bogerts B
Ann N Y Acad Sci; 2007 Jan; 1096():157-69. PubMed ID: 17405927
[TBL] [Abstract][Full Text] [Related]
5. Agmatinase, an inactivator of the putative endogenous antidepressant agmatine, is strongly upregulated in hippocampal interneurons of subjects with mood disorders.
Bernstein HG; Stich C; Jäger K; Dobrowolny H; Wick M; Steiner J; Veh R; Bogerts B; Laube G
Neuropharmacology; 2012 Jan; 62(1):237-46. PubMed ID: 21803059
[TBL] [Abstract][Full Text] [Related]
6. Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target.
Goeldner C; Ballard TM; Knoflach F; Wichmann J; Gatti S; Umbricht D
Neuropharmacology; 2013 Jan; 64():337-46. PubMed ID: 22992331
[TBL] [Abstract][Full Text] [Related]
7. Adult hippocampal neurogenesis: an actor in the antidepressant-like action.
Mendez-David I; Hen R; Gardier AM; David DJ
Ann Pharm Fr; 2013 May; 71(3):143-9. PubMed ID: 23622692
[TBL] [Abstract][Full Text] [Related]
8. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments.
Krystal JH; Sanacora G; Blumberg H; Anand A; Charney DS; Marek G; Epperson CN; Goddard A; Mason GF
Mol Psychiatry; 2002; 7 Suppl 1():S71-80. PubMed ID: 11986998
[TBL] [Abstract][Full Text] [Related]
9. Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat.
Sairanen M; O'Leary OF; Knuuttila JE; Castrén E
Neuroscience; 2007 Jan; 144(1):368-74. PubMed ID: 17049169
[TBL] [Abstract][Full Text] [Related]
10. A case series on the hypothesized connection between dementia and bipolar spectrum disorders: bipolar type VI?
Ng B; Camacho A; Lara DR; Brunstein MG; Pinto OC; Akiskal HS
J Affect Disord; 2008 Apr; 107(1-3):307-15. PubMed ID: 17889374
[TBL] [Abstract][Full Text] [Related]
11. Synaptoproteomics of learned helpless rats involve energy metabolism and cellular remodeling pathways in depressive-like behavior and antidepressant response.
Mallei A; Giambelli R; Gass P; Racagni G; Mathé AA; Vollmayr B; Popoli M
Neuropharmacology; 2011 Jun; 60(7-8):1243-53. PubMed ID: 21195720
[TBL] [Abstract][Full Text] [Related]
12. GABA and glutamate systems as therapeutic targets in depression and mood disorders.
Kendell SF; Krystal JH; Sanacora G
Expert Opin Ther Targets; 2005 Feb; 9(1):153-68. PubMed ID: 15757488
[TBL] [Abstract][Full Text] [Related]
13. The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders.
Schaffer A; McIntosh D; Goldstein BI; Rector NA; McIntyre RS; Beaulieu S; Swinson R; Yatham LN;
Ann Clin Psychiatry; 2012 Feb; 24(1):6-22. PubMed ID: 22303519
[TBL] [Abstract][Full Text] [Related]
14. [The role of zinc in the pathogenesis and treatment of affective disorders].
Siwek MS; Wróbel A; Dudek D; Nowak G; Zieba A
Psychiatr Pol; 2005; 39(5):899-909. PubMed ID: 16358590
[TBL] [Abstract][Full Text] [Related]
15. [The role of copper and magnesium in the pathogenesis and treatment of affective disorders].
Siwek M; Wróbel A; Dudek D; Nowak G; Zieba A
Psychiatr Pol; 2005; 39(5):911-20. PubMed ID: 16358591
[TBL] [Abstract][Full Text] [Related]
16. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
17. Behavioral and cognitive alterations, spontaneous seizures, and neuropathology developing after a pilocarpine-induced status epilepticus in C57BL/6 mice.
Müller CJ; Gröticke I; Bankstahl M; Löscher W
Exp Neurol; 2009 Sep; 219(1):284-97. PubMed ID: 19500573
[TBL] [Abstract][Full Text] [Related]
18. Chronic antidepressant treatment alters serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons.
Zhong P; Yan Z
Neuroscience; 2004; 129(1):65-73. PubMed ID: 15489029
[TBL] [Abstract][Full Text] [Related]
19. In vivo neuroimaging correlates of the efficacy of paroxetine in the treatment of mood and anxiety disorders.
Kilts C
Psychopharmacol Bull; 2003; 37 Suppl 1():19-28. PubMed ID: 14566198
[TBL] [Abstract][Full Text] [Related]
20. Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy.
Hasler G; Neumeister A; van der Veen JW; Tumonis T; Bain EE; Shen J; Drevets WC; Charney DS
Biol Psychiatry; 2005 Dec; 58(12):969-73. PubMed ID: 16043137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
